Changes in complement activation products after anti-VEGF injection for choroidal neovascularization in age-related macular degeneration and pachychoroid disease
Abstract We evaluated changes in the complement system resulting from anti-vascular endothelial growth factor (VEGF) in eyes with age-related choroidal neovascularization (CNV) including neovascular age-related macular degeneration, pachychoroid neovasculopathy, and polypoidal choroidal neovasculopa...
Main Authors: | Keiichiro Tanaka, Yasuharu Oguchi, Tomoko Omori, Yumi Ishida, Hiroaki Shintake, Ryutaro Tomita, Akihito Kasai, Masashi Ogasawara, Yukinori Sugano, Kanako Itagaki, Akira Ojima, Takeshi Machida, Hideharu Sekine, Tetsuju Sekiryu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-04-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-87340-6 |
Similar Items
-
The characteristics of choriocapillaris flow void in the unilateral polypoidal choroidal vasculopathy fellow eyes
by: Huajui Wu, et al.
Published: (2021-11-01) -
Age-Related Maculopathy Susceptibility 2 and Complement Factor H Polymorphism and Intraocular Complement Activation in Neovascular Age-Related Macular Degeneration
by: Yutaka Kato, MD, et al.
Published: (2022-06-01) -
Tear fluid and complement activation products in tears after ocular surgery
by: Hiroki Maehara, et al.
Published: (2023-07-01) -
Complement activation products in tears of dry eye and meibomian gland dysfunction
by: Hiroki Maehara, et al.
Published: (2024-01-01) -
Foveal structure during the induction phase of anti-vascular endothelial growth factor therapy for occult choroidal neovascularization in age-related macular degeneration
by: Kano M, et al.
Published: (2015-11-01)